VFA
Values First Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,032
| Closed | -$109K | – | 237 |
|
|
2024
Q4 | $109K | Sell |
36,032
-38,497
| -52% | -$117K | 0.06% | 188 |
|
|
2024
Q3 | $274K | Sell |
74,529
-396
| -0.5% | -$1.46K | 0.15% | 128 |
|
|
2024
Q2 | $306K | Buy |
74,925
+3,859
| +5% | +$15.8K | 0.18% | 122 |
|
|
2024
Q1 | $1.12M | Buy |
71,066
+22,998
| +48% | +$362K | 0.66% | 46 |
|
|
2023
Q4 | $728K | Buy |
48,068
+7,148
| +17% | +$108K | 0.44% | 76 |
|
|
2023
Q3 | $821K | Buy |
40,920
+10,362
| +34% | +$208K | 0.53% | 59 |
|
|
2023
Q2 | $862K | Buy |
30,558
+22,922
| +300% | +$647K | 0.52% | 58 |
|
|
2023
Q1 | $131K | Buy |
+7,636
| New | +$131K | 0.08% | 155 |
|
|
2022
Q1 | – | Sell |
-2,542
| Closed | -$214K | – | 180 |
|
|
2021
Q4 | $214K | Buy |
+2,542
| New | +$214K | 0.13% | 154 |
|